Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 78

Sort by

Sort Order Select

Journal Articles

The Use of Chromogenic Factor VIII Assay Changes Treatment Approach in a Portion of Mild Hemophilia A Patients with Factor VIII Assay Discrepancy

Muntadhar Al Moosawi, MD, Karen L. Dallas, MD FRCPC, Steven Wong, Shannon Jackson, MD FRCPC

Blood (2019) 134 (Supplement_1): 906.

https://doi.org/10.1182/blood-2019-123799

Published: 2019

Journal Articles

A Machine Learning Approach Identifies a 30-Gene Model That Predicts Sensitivity to Selinexor in Multiple Myeloma

Alessandro Lagana, PhD, Sherry Bhalla, Adolfo Aleman, Anna Huo-Chang Mei, MS, Violetta Leshchenko, PhD, Yosef Landesman, PhD, David Melnekoff, BS,MS, Itai Beno, PhD, Deepu Madduri, MD, Joshua R Richter, MD, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2019) 134 (Supplement_1): 3101.

https://doi.org/10.1182/blood-2019-130753

Published: 2019

Journal Articles

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide

Giuseppe Lia, PhD, Clara Di Vito, PhD, Marta Tapparo, PhD, Stefania Bruno, Elisa Zaghi, Michela Calvi, Lucia Brunello, Jacopo Mariotti, MD, Lorenzo Comba, Luisa Giaccone, Martina Fascì, Mario Boccadoro, Andrea Evangelista, MSc, Luca Castagna, MD, Giovanni Camussi, Domenico Mavilio, Benedetto Bruno, MD

Blood (2019) 134 (Supplement_1): 598.

https://doi.org/10.1182/blood-2019-126521

Published: 2019

Journal Articles

The Children's Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine Learning

Blood (2019) 134 (Supplement_1): 635.

https://doi.org/10.1182/blood-2019-126128

Published: 2019

Journal Articles

Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Blood (2019) 134 (Supplement_1): 460.

https://doi.org/10.1182/blood-2019-121870

Published: 2019

Journal Articles

Clinical Relevance of MYD88 L265P Mutation and Interleukin-10 Level in Cerebrospinal Fluid of Patients with Both Newly Diagnosed and Relapsed Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Blood (2019) 134 (Supplement_1): 4114.

https://doi.org/10.1182/blood-2019-128298

Published: 2019

Journal Articles

Prediction of High-Risk Group of Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using a CT-Based Radiomics Model with Machine Learning

Raoul Santiago, MDMSc, Johanna Ortiz Jimenez, MD, Reza Forghani, MD PhD, Nikesh Muthukrishnan, MEng, Olivier Del Corpo, BSC, MSc, Shairabi Karthigesu, Muhammad Yahya Haider, Caroline Reinhold, MD MSc, Sarit Assouline, MD

Blood (2019) 134 (Supplement_1): 4136.

https://doi.org/10.1182/blood-2019-126745

Published: 2019

Journal Articles

PTBP1 Regulates Alternative Splicing of Apoptotic Protein: Implications in CLL and Ibrutinib Resistance

Huayuan Zhu, Xiaotong Li, Xinqi Zheng, Juejin Wang, Hanning Tang, Wei Xu, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 1290.

https://doi.org/10.1182/blood-2019-126945

Published: 2019

Journal Articles

Urine Proteomic Analysis Reveals Disease-Specific Patterns in Pediatric Patients with Classical Hodgkin's Disease(HD). an Addon Study to the Euronet-PHL-C2 Trial

Blood (2019) 134 (Supplement_1): 2804.

https://doi.org/10.1182/blood-2019-125611

Published: 2019

Journal Articles

A Signature of T Cell Exhaustion Is Enriched in the Bone Marrow (BM) of AML Patients and Shared with Immune Exhaustion Signatures of Solid Tumors

Hanna A. Knaus, MD, Hubert Hackl, Amanda Blackford, Sofia Berglund, Raul Montiel-Esparza, Joshua F Zeidner, MD, Ivana Gojo, MD, Leo Luznik, MD

Blood (2019) 134 (Supplement_1): 2711.

https://doi.org/10.1182/blood-2019-128742

Published: 2019

Journal Articles

Individualized Prediction of Follicular Lymphoma Risk Using a Combination of Blood t(14;18) Frequency Years before Diagnosis and a Polygenic Risk Score (PRS) of 9 SNPs Associated with Follicular Lymphoma Susceptibility

Herve Ghesquieres, MD PhD, Youenn Drouet, PhD, Manon Zala, Paolo Vineis, PhD, Gilles A. Salles, MD PhD, Bertrand Nadel, PhD, Sandrine Roulland, PharmD, PhD

Blood (2019) 134 (Supplement_1): 2775.

https://doi.org/10.1182/blood-2019-130618

Published: 2019

Journal Articles

A 3-LncRNA Risk Scoring System for Prognosis of Adult Acute Myeloid Leukemia

Yuandong Feng, MD, Yachun Jia, Ying Shen, MD, Hongli Chen, Yue Peng, Ru Zhang, MD, Yun Yang, MD, Jian-Li Wang, MD PhD, Ju Bai, PhD, Fang-Xia Wang, MD PhD, Yan Xu, Aili He, MD

Blood (2018) 132 (Supplement 1): 5253.

https://doi.org/10.1182/blood-2018-99-114549

Published: 2018

Journal Articles

Disappearance of Slan-Positive Non-Classical Monocytes As a New Parameter for the Diagnosis of Chronic Myelomonocytic Leukemia with Associated Inflammatory State

Sihem Tarfi, PharmD, Bouchra Badaoui, PharmD, Nicolas Freynet, PharmD, Margot Morabito, Jeffie Lafosse, Andrea Toma, MD PhD, Pierre Fenaux, MD PhD, Eric Solary, MD PhD, Dorothée Selimoglu-Buet, PhD, Orianne Wagner Ballon, MD PhD

Blood (2018) 132 (Supplement 1): 4376.

https://doi.org/10.1182/blood-2018-99-116451

Published: 2018

Journal Articles

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

Blood (2018) 132 (Supplement 1): 4357.

https://doi.org/10.1182/blood-2018-99-111838

Published: 2018

Journal Articles

Peripheral Blood Blast Clearance As an Independent Predictor of Clinical Response and Outcomes in Acute Myeloid Leukemia

Noa G. Holtzman, MD, Firas El Chaer, MD, Omer Ali, MD, Ameet Patel, MD, Maria R. Baer, MD, Vu H. Duong, MD, Edward A. Sausville, MD PhD, Arash Etemadi, MD PhD, Ashkan Emadi, MD PhD

Blood (2018) 132 (Supplement 1): 2684.

https://doi.org/10.1182/blood-2018-99-115512

Published: 2018

Journal Articles

Prediction of Severe Acute Graft-Versus-Host Disease (aGVHD) Based on Whole Transcriptome Sequencing of Donor CD4 T Cells

Silvy Lachance, MDFRCPC, Jonathan Séguin, MSc., Ann Brasey, PhD, Jean-Philippe Laverdure, PhD, Vincent T Ho, MD, Jerome Ritz, MD, Jan Storek, MD PhD, Denis-Claude Roy, MD, Lambert Busque, MD, Sébastien Lemieux, PhD, Claude Perreault, MD

Blood (2017) 130 (Supplement 1): 3249.

https://doi.org/10.1182/blood.V130.Suppl_1.3249.3249

Published: 2017

Journal Articles

Acute Kidney Injury in Chemotherapy for Children with Pediatric Malignancy

Ryuta Washio, MD, Masaya Takahashi, MD, Takashi Yamazoe, Aya Kang, MD, Yukihiro Noda, MD PhD, Hirohide Kawasaki, MD, Kazunari Kaneko, MD PhD

Blood (2017) 130 (Supplement 1): 5671.

https://doi.org/10.1182/blood.V130.Suppl_1.5671.5671

Published: 2017

Journal Articles

An Artificial Intelligence Approach for Predicting Allogeneic Hematopoietic Stem Cell Transplantation Outcome By Detecting Pre-Transplant Minimal Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry Data

Chi-Cheng Li, MD, Bor-Sheng Ko, MD, PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Pei-Fang Weng, BS, Hsin-An Hou, MD, PhD, Xiu-Wen Liao, MS, Chien-Ting Lin, MD, Jia-Hou Liu, MD, Hsun-I Sun, Hwei-Fang Tien, MD, PhD, Chi-Chun Lee, PhD, Jih-Luh Tang, MD,PhD

Blood (2017) 130 (Supplement 1): 2042.

https://doi.org/10.1182/blood.V130.Suppl_1.2042.2042

Published: 2017

Journal Articles

A Knowledge-Based Approach for Clinical Annotation of Oncogenic Variants to Support Patient-Tailored Diagnosis in Myeloid Disease

Blood (2017) 130 (Supplement 1): 1414.

https://doi.org/10.1182/blood.V130.Suppl_1.1414.1414

Published: 2017

Journal Articles

Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide

Takahiro Kobayashi, MD, Masatomo Miura, Takenori Niioka, Yuki Fujioka, Maiko Abumiya, Tomoko Yoshioka, Yoshihiro Kameoka, Hiroyoshi Nishikawa, Naoto Takahashi

Blood (2017) 130 (Supplement 1): 3846.

https://doi.org/10.1182/blood.V130.Suppl_1.3846.3846

Published: 2017

NARROW

The Use of Chromogenic Factor VIII Assay Changes Treatment Approach in a Portion of Mild Hemophilia A Patients with Factor VIII Assay Discrepancy

A Machine Learning Approach Identifies a 30-Gene Model That Predicts Sensitivity to Selinexor in Multiple Myeloma

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide

The Children's Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine Learning

Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Clinical Relevance of MYD88 L265P Mutation and Interleukin-10 Level in Cerebrospinal Fluid of Patients with Both Newly Diagnosed and Relapsed Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Prediction of High-Risk Group of Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using a CT-Based Radiomics Model with Machine Learning

PTBP1 Regulates Alternative Splicing of Apoptotic Protein: Implications in CLL and Ibrutinib Resistance

Urine Proteomic Analysis Reveals Disease-Specific Patterns in Pediatric Patients with Classical Hodgkin's Disease(HD). an Addon Study to the Euronet-PHL-C2 Trial

A Signature of T Cell Exhaustion Is Enriched in the Bone Marrow (BM) of AML Patients and Shared with Immune Exhaustion Signatures of Solid Tumors

Individualized Prediction of Follicular Lymphoma Risk Using a Combination of Blood t(14;18) Frequency Years before Diagnosis and a Polygenic Risk Score (PRS) of 9 SNPs Associated with Follicular Lymphoma Susceptibility

A 3-LncRNA Risk Scoring System for Prognosis of Adult Acute Myeloid Leukemia

Disappearance of Slan-Positive Non-Classical Monocytes As a New Parameter for the Diagnosis of Chronic Myelomonocytic Leukemia with Associated Inflammatory State

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

Peripheral Blood Blast Clearance As an Independent Predictor of Clinical Response and Outcomes in Acute Myeloid Leukemia

Prediction of Severe Acute Graft-Versus-Host Disease (aGVHD) Based on Whole Transcriptome Sequencing of Donor CD4 T Cells

Acute Kidney Injury in Chemotherapy for Children with Pediatric Malignancy

An Artificial Intelligence Approach for Predicting Allogeneic Hematopoietic Stem Cell Transplantation Outcome By Detecting Pre-Transplant Minimal Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry Data

A Knowledge-Based Approach for Clinical Annotation of Oncogenic Variants to Support Patient-Tailored Diagnosis in Myeloid Disease

Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only